Company intelligence / Profile preview

Circufiber

unspecified, North Carolina, United Statescircufiber.com ↗

Ownership: Private
Development stage: Commercial

Overview

Clinical studies at Yale School of Medicine demonstrated that Circufiber socks significantly improve transcutaneous oximetry (TcPO2) levels—an indicator of improved blood flow—in diabetic patients compared to placebo socks. In a nationwide Quality of Life Study, 85% of participants reported improvement in one or more conditions after two weeks; by six weeks this rose to 97%, including improvements in swelling and pain.

Therapeutic areas: Endocrinology
Modalities: Device (specifically, textile-based device with infrared technology)
Industry: Therapeutic Medical Devices

Partnerships

Yale School of Medicine clinical research collaboration

Beyond the preview

Go deeper on Circufiber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circufiber.

Explore the full profile